Abstract
Episodic ataxia type 2 (EA2) is a hereditary disorder characterized by paroxysmal attacks of ataxia, vertigo and nausea, due to mutations in the CACNA1A gene, which encodes for α1 subunit of the P/Q-type voltage-gated Ca2+ channel (CaV2.1). Other manifestations may be associated to CACNA1A mutations, such as migraine and epilepsy. The correlation between episodic ataxia and epilepsy is often underestimated and misdiagnosed. Clinical presentation of EA2 varies among patients and within the same family, and the same genetic mutation can lead to different clinical phenotypes. We herewith describe an Italian family presenting with typical EA2 and, in two of the family members (patients II.3 and III.1), epileptic seizures. The sequencing revealed a heterozygous deletion of 6 nucleotides in exon 28 of CACNA1A gene, present in all affected patients. Evidence suggests that mutations of CACNA1A, conferring a loss/reduction of CaV2.1 function, lead to an increase of thalamocortical excitation that contributes to epileptiform discharges. Our description highlights intra-family variability of EA2 phenotype and suggests that mutations in the CACNA1A gene should be suspected in individuals with focal or generalized epilepsy, associated with a family history of episodic ataxia.
Similar content being viewed by others
References
Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Neurology 62(1):17–22. https://doi.org/10.1212/01.wnl.0000101675.61074.50
Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521–555. https://doi.org/10.1146/annurev.cellbio.16.1.52
Mantuano E, Romano S, Veneziano L, Gellera C, Castellotti B, Caimi S et al (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci 291(1–2):30–36. https://doi.org/10.1016/j.jns.2010.01.010
Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaben J et al (2014) Consensus paper: management of degenerative cerebellar disorders. Cerebellum 13(2):248–268. https://doi.org/10.1007/s12311-013-0531-6
Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T et al (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77(3):269–275. https://doi.org/10.1212/WNL.0b013e318225ab07
Guterman EL, Yurgionas B, Nelson AB (2016) Pearls & Oy-sters: episodic ataxia type 2: case report and review of the literature. Neurology 86:e239–e241. https://doi.org/10.1212/WNL.0000000000002743
den Dunnen JT, Dalgleish R, Maglot DR, Hart RK, Greenblatt MS, McGowan-Giordan J et al (2016) HGVS Recommendations for the description of sequence variants: 2016 update. Hum Mutat 37(6):564–569. https://doi.org/10.1002/humu.22981 (Epub 2016 Mar 25)
Baloh RW, Yue Q, Furman JM, Nelson SF (1997) Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41(1):8–16. https://doi.org/10.1002/ana.410410105
Rajakulendran S, Graves TD, Labrum RW, Kotzadimitriou D, Eunson L, Davis MB et al (2010) Genetic and functional characterization of the P/Q calcium channel in episodic ataxia with epilepsy. J Physiol 588(Pt 11):1905–1913. https://doi.org/10.1113/jphysiol.2009.186437
Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R et al (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127(Pt 12):2682–2692. https://doi.org/10.1093/brain/awh301
Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi V, Kullmann D, Hanna MG (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358(9284):801–807. https://doi.org/10.1016/S0140-6736(01)05971-2
Jung J, Testard H, Tournier-Lasserve E, Riant F, Vallet AE, Berroir S, Broussolle E (2010) Phenotypic variability of episodic ataxia type 2 mutations: a family study. Eur Neurol 64:114–116. https://doi.org/10.1159/000315145
Damaj L, Lupien-Meilleur A, Lortie A, Riou E, Ospina LH, Gagnon L et al (2015) CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet 23(11):1505–1512. https://doi.org/10.1038/ejhg.2015.21
Holtmann M, Opp J, Tokarzewski M, Korn-Merker E (2002) Human epilepsy, episodic ataxia type 2, and migraine. Lancet 359(9301):170–171. https://doi.org/10.1016/S0140-6736(02)07355-5
Angelini C, Van Gils J, Bigourdan A, Jouk PS, Lacombe D, Menegon P et al (2019) Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. Eur J Med Genet 62(6):103530. https://doi.org/10.1016/j.ejmg.2018.08.011
Perucca E (1997) A pharmacological and clinical review on Topiramate, a new antiepileptic drug. Pharmacol Res 35(4):241–256. https://doi.org/10.1006/phrs.1997.0124
Matsushita K, Wakamori M, Rhyu IJ, Arii T, Oda S, Mori Y, Imoto K (2002) Bidirectional alterations in cerebellar synaptic transmission of tottering and rolling Ca2+ channel mutant mice. J Neurosci 22(11):4388–4398. https://doi.org/10.1523/JNEUROSCI.22-11-31404388.2002
Talley EM, Solòrzano G, Depaulis A, Perez-Reyes E, Bayliss DA (2000) Low-voltage activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 75(1):159–165. https://doi.org/10.1016/s0169-328x(99)00307-1
Llinàs RR, Choi S, Urbano FJ, Shin HS (2007) Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice. Proc Natl Acad Sci USA 104(45):17819–17824. https://doi.org/10.1073/pnas.0707945104
Yi Z, Mori M, Burgess DL, Noebels JL (2002) Mutations in high voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 22(15):6362–6371. https://doi.org/10.1523/JNEUROSCI.22-15-06362.2002
Rossignol E, Kruglikov I, van den Maagdenberg AMJM, Rudy B, Fishell G (2013) Cav2.1 ablation in cortical interneurons selectively impairs fast-spiking basket cells and causes generalized seizures. Ann Neurol 74(2):209–222. https://doi.org/10.1002/ana.23913
Vigues S, Gastaldi M, Chabret C, Massacrier A, Cau P, Valmier J (1999) Regulation of calcium channel alpha(1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy. Neurobiol Dis 6(4):288–301. https://doi.org/10.1006/nbdi.1999.0248
Das A, Wallace GC, Holmes C, McDowell ML, Smith JA, Marshall JD et al (2012) Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocytes activation, inflammation, and altered expression of channels and receptors. Neuroscience 220:237–246. https://doi.org/10.1016/j.neuroscience.2012.06.002
Lv N, Qu J, Long H, Zhou L, Cao Y, Long L et al (2015) Association study between polymorphisms in the CACNA1A, CACNA1C and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population. Seizure 30:64–69. https://doi.org/10.1016/j.seizure.2015.05.013
Song I, Kim D, Choi S, Sun M, Kim Y, Shin HS (2004) Role of the alpha1GT-type calcium channel in spontaneous absence seizures in mutant mice. J Neurosci 24(22):5249–5257. https://doi.org/10.1523/JNEUROSCI.5546-03.2004
Rajakulendran S, Hanna MG (2016) The role of calcium channels in epilepsy. Cold Spring Harb Perspect Med 6(1):a022723. https://doi.org/10.1101/cshperspect.a022723
Mantuano E, Veneziano L, Spadaro M, Giunti P, Guida S, Leggio MG et al (2004) Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Ca(v)2.1 causing episodic ataxia 2. J Med Genet 41(6):e82. https://doi.org/10.1136/jmg.2003.015396
Indelicato E, Unterberger I, Nachbauer W, Eigentler A, Amprosi M, Zeiner F et al (2021) The electrophysiological footprint of CACNA1A disorders. J Neurol. https://doi.org/10.1007/s00415-021-10415-x
Acknowledgements
Data access, responsibility, and analysis: all the authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. We would like to thank the family for participating in this study.
Funding
No funding sources.
Author information
Authors and Affiliations
Contributions
LV: design and conceptualized study; acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content; study supervision. GP: design and conceptualized study; acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content; study supervision. AN: acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content. IL: acquisition of data; interpreted the data; drafted and revised the manuscript for intellectual content. EB: acquisition of data; interpreted the data; revised the manuscript for intellectual content. MV, FC and GLG: revised the manuscript for intellectual content; study supervision. All the authors approved the submitted version.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
The study was performed in accordance with the Declaration of Helsinki.
Informed consent
Informed consent was obtained.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Verriello, L., Pauletto, G., Nilo, A. et al. Epilepsy and episodic ataxia type 2: family study and review of the literature. J Neurol 268, 4296–4302 (2021). https://doi.org/10.1007/s00415-021-10555-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10555-0